Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10032906HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS10040510HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS10042489HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001392HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001393HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001394HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30013875HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30088317HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019456HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019457HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TCGA Plot Options
Drug Information
GeneJAK1
DrugBank IDDB11763
Drug NameMomelotinib
Target IDBE0004145
UniProt IDP23458
Regulation Typeinhibitor
PubMed IDs31450973
CitationsXu L, Feng J, Gao G, Tang H: Momelotinib for the treatment of myelofibrosis. Expert Opin Pharmacother. 2019 Nov;20(16):1943-1951. doi: 10.1080/14656566.2019.1657093. Epub 2019 Aug 26.
GroupsApproved; Investigational
Direct ClassificationPhenylpyrimidines
SMILESO=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1
Pathways
PharmGKB
ChEMBLCHEMBL1078178